Monday, May 10, 2021 6:38:33 PM
While it wasn’t necessarily what I wanted to hear, I did appreciate his candid reponse. It reassured me of his character and reaffirmed my faith in ENRT for several reasons. He’s being honest about the delays, and the lack of patent news isn’t a shady attempt to hide bad news from investors, there’s simply nothing to report at the moment. But they are still eager to get the patent approved because they DO still believe they have some very valuable new technology. So I guess impatient investors or day talradera may continue to drive the price lower in the meantime, but if you truly have faith in the company and the potential patents, there’s nothing bad happening that should make you want or need to sell. If you can afford to buy more, this might be a great time to take advantage of the brutal sell off that’s occurred. I’m still long. GLTA.
Recent ENRT News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/01/2024 06:21:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 03:41:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/11/2024 08:38:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 06:24:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 02:01:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 02:02:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 09:09:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 10:06:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 01:06:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/12/2023 08:29:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 09:24:54 PM
- MWRK Positions For High Growth In $3.5 Trillion Metaverse Market Popularized By META • InvestorsHub NewsWire • 05/03/2023 04:24:58 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM